Michael J. LaBarre - Nov 15, 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF TECHNICAL OFFICER
Signature
/s/ James R. Oehler as attorney-in-fact for Michael J. LaBarre
Stock symbol
HALO
Transactions as of
Nov 15, 2022
Transactions value $
-$541,263
Form type
4
Date filed
11/16/2022, 06:25 PM
Previous filing
Feb 17, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale -$372K -6.88K -3.97% $54.12 166K Nov 15, 2022 Direct F1, F2
transaction HALO Common Stock Sale -$437 -8 0% $54.61 166K Nov 15, 2022 Direct F1
transaction HALO Common Stock Sale -$169K -3.12K -1.87% $54.14 163K Nov 15, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents a weighted average sales price per share. These shares were sold at prices ranging from $53.59 to $54.50. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.